ArticleGastro hep advances2026
Focused Shear Wave Elastography to Assess Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Handheld Probe for Focused Shear Wave Transient Elastography.Annals of biomedical engineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Liver fibrosis assessment using transient elastography (TE) or 2-dimensional shear wave elastography (2DSWE) exhibits high rates of failure and unreliability in patients with obesity. Novel focused shear wave elastography (fSWE) aims to enhance liver stiffness measurement (LSM) in patients with obesity and MASLD by using shear waves that converge toward the LSM region, rather than diverge as in TE and 2DSWE. The aim of the present study was to demonstrate the feasibility of LSM by fSWE, with comparison to TE and 2DSWE, in a pilot cohort of MASLD patients. Methods: We prospectively enrolled 26 adult subjects at a single clinical site. For each subject, LSM was performed using fSWE, TE, and 2DSWE and baseline clinical characteristics were obtained in a single visit. Fibrosis stage was known in 19 subjects who had prior biopsy or LSM by magnetic resonance elastography. Results: LSM was obtained in 15 subjects by fSWE, 26 subjects by TE, and 23 subjects by 2DSWE. The correlation between TE and fSWE was 92% and between TE and 2DSWE was 67%. In the subset of subjects with body mass index >35 kg/m Conclusion: A novel elastography technique, fSWE, exhibited high concordance with TE and better diagnostic performance than 2DSWE. If confirmed in larger prospective studies, fSWE may represent a promising screening strategy for patients with coexisting MASLD and obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.